These outcomes hold great promise for the use of compound 14 as a safe antioxidant agent and its inhibition of cholinesterase is of interest concerning neurodegenerative disorders such as Alzheimer’s disease. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.